These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 20203531

  • 1. Neuroprotection without immunomodulation is not sufficient to reduce first relapse severity in experimental autoimmune encephalomyelitis.
    Hasseldam H, Johansen FF.
    Neuroimmunomodulation; 2010; 17(4):252-64. PubMed ID: 20203531
    [Abstract] [Full Text] [Related]

  • 2. Cannabinoid treatment renders neurons less vulnerable than oligodendrocytes in Experimental Autoimmune Encephalomyelitis.
    Hasseldam H, Johansen FF.
    Int J Neurosci; 2011 Sep; 121(9):510-20. PubMed ID: 21671839
    [Abstract] [Full Text] [Related]

  • 3. Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects.
    de Lago E, Moreno-Martet M, Cabranes A, Ramos JA, Fernández-Ruiz J.
    Neuropharmacology; 2012 Jun; 62(7):2299-308. PubMed ID: 22342378
    [Abstract] [Full Text] [Related]

  • 4. Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis.
    Croxford JL, Pryce G, Jackson SJ, Ledent C, Giovannoni G, Pertwee RG, Yamamura T, Baker D.
    J Neuroimmunol; 2008 Jan; 193(1-2):120-9. PubMed ID: 18037503
    [Abstract] [Full Text] [Related]

  • 5. Future neuroprotective strategies.
    Sättler MB, Bähr M.
    Exp Neurol; 2010 Sep; 225(1):40-7. PubMed ID: 19716365
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic effects of combined treatment with ribavirin and tiazofurin on experimental autoimmune encephalomyelitis development: clinical and histopathological evaluation.
    Stojkov D, Lavrnja I, Pekovic S, Dacic S, Bjelobaba I, Mostarica-Stojkovic M, Stosic-Grujicic S, Jovanovic S, Nedeljkovic N, Rakic L, Stojiljkovic M.
    J Neurol Sci; 2008 Apr 15; 267(1-2):76-85. PubMed ID: 17996253
    [Abstract] [Full Text] [Related]

  • 7. The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination.
    Tomas-Roig J, Wirths O, Salinas-Riester G, Havemann-Reinecke U.
    CNS Neurosci Ther; 2016 May 15; 22(5):387-95. PubMed ID: 26842941
    [Abstract] [Full Text] [Related]

  • 8. Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R+WIN55,212.
    Croxford JL, Miller SD.
    J Clin Invest; 2003 Apr 15; 111(8):1231-40. PubMed ID: 12697742
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Administration of a monomeric CCL2 variant to EAE mice inhibits inflammatory cell recruitment and protects from demyelination and axonal loss.
    Brini E, Ruffini F, Bergami A, Brambilla E, Dati G, Greco B, Cirillo R, Proudfoot AE, Comi G, Furlan R, Zaratin P, Martino G.
    J Neuroimmunol; 2009 Apr 30; 209(1-2):33-9. PubMed ID: 19232440
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Idazoxan attenuates spinal cord injury by enhanced astrocytic activation and reduced microglial activation in rat experimental autoimmune encephalomyelitis.
    Wang XS, Chen YY, Shang XF, Zhu ZG, Chen GQ, Han Z, Shao B, Yang HM, Xu HQ, Chen JF, Zheng RY.
    Brain Res; 2009 Feb 09; 1253():198-209. PubMed ID: 19083996
    [Abstract] [Full Text] [Related]

  • 19. The potential protective effects of cannabinoid receptor agonist WIN55,212-2 on cognitive dysfunction is associated with the suppression of autophagy and inflammation in an experimental model of vascular dementia.
    Wang DP, Yin H, Kang K, Lin Q, Su SH, Hai J.
    Psychiatry Res; 2018 Sep 09; 267():281-288. PubMed ID: 29945070
    [Abstract] [Full Text] [Related]

  • 20. Combination therapy of lovastatin and rolipram provides neuroprotection and promotes neurorepair in inflammatory demyelination model of multiple sclerosis.
    Paintlia AS, Paintlia MK, Singh I, Skoff RB, Singh AK.
    Glia; 2009 Jan 15; 57(2):182-93. PubMed ID: 18720408
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.